Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-2009)

J Clin Immunol. 2011 Jun;31(3):297-308. doi: 10.1007/s10875-010-9493-3. Epub 2011 Jan 18.

Abstract

Two hundred and one patients have been diagnosed with primary immunodeficiency diseases (PIDs) in our center from January 2004 to December 2009. The male-to-female ratio was 5.29:1. Spectrums of PIDs were as follows: predominantly antibody deficiency disease was the most common category (94 patients, 48.2%), followed by other well-defined immunodeficiency syndromes (40 patients, 20.5%), combined T and B cell immunodeficiencies (33 patients, 16.9%), congenital defects of phagocyte number and/or function (21 patients, 10.8%), and diseases of immune dysregulation (six patients, 3.1%). Agammaglobulinemia was the most frequent disease type. The median of diagnosis lag was 18.0 months. Pneumonia was the most common manifestation of PID patients. Some manifestations were prone to concentrate in certain diseases. As for therapy, 99 patients (50.8%) received intravenous immunoglobulin replacement therapy; 13 patients received hematopoietic stem cell transplantation and nine of them were still alive. In this study, we sought to describe and analyze the distribution, clinical features, and therapy methods of PIDs among children diagnosed in our country and to compare with reports from other countries and regions.

MeSH terms

  • Adolescent
  • Agammaglobulinemia / epidemiology
  • Agammaglobulinemia / immunology*
  • Agammaglobulinemia / mortality
  • Agammaglobulinemia / pathology
  • Agammaglobulinemia / therapy
  • Anti-Bacterial Agents / pharmacology
  • Asian People
  • Child
  • Child, Preschool
  • Common Variable Immunodeficiency / epidemiology
  • Common Variable Immunodeficiency / immunology*
  • Common Variable Immunodeficiency / mortality
  • Common Variable Immunodeficiency / pathology
  • Common Variable Immunodeficiency / therapy
  • Consanguinity
  • Family
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunoglobulin Isotypes / analysis
  • Immunoglobulins / immunology
  • Immunoglobulins / pharmacology*
  • Incidence
  • Infant
  • Infant, Newborn
  • Longitudinal Studies
  • Male
  • Phagocyte Bactericidal Dysfunction / epidemiology
  • Phagocyte Bactericidal Dysfunction / immunology*
  • Phagocyte Bactericidal Dysfunction / mortality
  • Phagocyte Bactericidal Dysfunction / pathology
  • Phagocyte Bactericidal Dysfunction / therapy
  • Retrospective Studies
  • Severe Combined Immunodeficiency / epidemiology
  • Severe Combined Immunodeficiency / immunology*
  • Severe Combined Immunodeficiency / mortality
  • Severe Combined Immunodeficiency / pathology
  • Severe Combined Immunodeficiency / therapy
  • Survival Rate

Substances

  • Anti-Bacterial Agents
  • Immunoglobulin Isotypes
  • Immunoglobulins